Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read General business news Sun Capital to buy filtration technologies firm Koch Separation Solutions In a move that promises to amplify its standing in the industry, Sun Capital Partners, a renowned private… byPallavi MadhirajuAugust 17, 2023